Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Thursday Mar 09, 2023
Emerging data with immunotherapy in ESCC and potential impact for clinical practice
Thursday Mar 09, 2023
Thursday Mar 09, 2023
touchTALKS for touchONCOLOLOGY
Listen to a leading expert discussing the recent developments in esophageal cancer with a primary focus on esophageal squamous cell carcinoma (ESCC)
The expert:
- Dr Elizabeth Smyth, Addenbrooke’s Hospital, Cambridge, UK
Overview:
Part 1: Insights from 2021 (0:00)
Part 2: Insights from ASCO and ESMO GI 2022 (13:29)
Part 3: Insights from the updated ESMO Clinical Practice Guideline (24:08)
Part 4: Insights from ESMO Asia 2022 and ASCO GI 2023 (34:53)
This touchPODCAST is for HCPs only.
Funding for this touchPODCAST is from an independent medical education grant from Novartis. This activity is provided by touchIME.
For further information please visit: https://touchoncologyime.org/congress-renal-cell-carcinoma-asco-gu-2023
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.